A phase II study of gemcitabine plus capecitabine (GC) in heavily pre-treated metastatic breast cancer patients. The Swedish GC Breast Cancer Study Group
A. Malmstrom, J. Hansen, L. Malmberg, L. Carlsson, J.H. Svensson, J. Ahlgren, C. Ahlin, T. Jansson, R. WestbergVolume:
6
Year:
2008
Language:
english
DOI:
10.1016/s1359-6349(08)70736-5
File:
PDF, 74 KB
english, 2008